There is a treatment involving peptides that RFK Jr. supports and wants to make more accessible. However, FDA staff have expressed concerns about the treatment, and an advisory panel review is upcoming. The outcome is uncertain, with some reports suggesting the FDA may ease restrictions on peptides, while others indicate that RFK Jr.'s plans to widen access may face complications.